Prof. He Jianxing: Chinese original findings of lung cancer screening in non-high-risk populations rewrites global guidelines
On May 20, the 12th session of the “CACA Frontline Broadcast” academic conference, organized by the Chinese Anti-Cancer Association (CACA), concluded successfully in a hybrid format. During the conference, Professor He Jianxing and Professor Liang Wenhua's team from the First Affiliated Hospital of Guangzhou Medical University shared their research findings recently published in the Journal of the American Medical Association (JAMA), titled “Non–Risk-Based Lung Cancer Screening With Low-Dose Computed Tomography.” Professor He provided an in-depth overview of the study's background, rationale, and strategic considerations.
Prof. Feng Ye / Prof. ZhengtuLi team from the First Affiliated Hospital of Guangzhou MedicalUniversity/Guangzhou Institute of Respiratory Health/State Key Laboratory of Respiratory Disease published their latest research findings in the internationally authoritative journal npj Biofilms and Microbiomes on November 13, 2024.
In October 2024, the results of a drug clinical trial on the treatment of patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) using N-acetylcysteine, which was led by the team of Prof. Pixin Ran from the First Affiliated Hospital of Guangzhou Medical University / National Key Laboratory of Respiratory Disease / National Center for Respiratory Medicine / National Clinical Research Center for Respiratory Diseases / Guangzhou National Laboratory, were published in the Nature Communications.